MErCuRIC year 5 meeting

Van Schaeybroeck, S. (Organiser)

School of Medicine, Dentistry and Biomedical Sciences

Activity: Participating in or organising an event types › Participation in conference

Period	18 Oct 2019
Event type	Conference
Location	Paris, FranceShow on map
Degree of Recognition	International

Related content

Research output
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)
Research output: Contribution to journal › Article › peer-review
A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers
Research output: Contribution to journal › Article › peer-review